Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Fleury SA (FLRY3)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
14.61 -0.05    -0.34%
00:00:04 - Closed. Currency in BRL ( Disclaimer )
  • Volume: 2,941,300
  • Bid/Ask: 14.51 / 14.80
  • Day's Range: 14.55 - 14.89
Type:  Equity
Market:  Brazil
ISIN:  BRFLRYACNOR5 
FLEURY ON 14.61 -0.05 -0.34%

FLEURY ON Company Profile

 
Read the FLEURY ON company profile to learn more about the business and the management team. View Fleury SA facts about employee data, company products and services, and contact information.
IndustryHealthcare Providers & Services
SectorHealthcare
Employees

17500

Equity Type

ORD

Fleury S.A., together with its subsidiaries, provides medical services in the diagnostic, treatment, clinical analysis, health management, medical care, orthopedics, and ophthalmology areas in Brazil. The company operates through three segments: Diagnostic Medicine, Integrated Medicine, and Dental. It provides laboratory and imaging tests, genomics, health management and platform, diagnostic information, check-up and reference laboratory, clinic day, infusion center, orthopedics and ophthalmology, dental imaging tests, and diagnostic imaging services. The company also offers Saúde I, a digital healthcare platform that provides services, including scheduling and performing teleconsultations, and face-to-face consultations, as well as scheduling and accessing diagnostic test results, electronic medical record, and self-manage health issues. It operates customer service units and hospital-based units under the Fleury, Felippe Mattoso, Labs a+, Diagnoson a+, Papaiz, Serdil, LAFE, Instituto de Radiologia de Natal, Centro de Patologia Clínica, Diagmax, Santécorp, a+SP, CIP, Saha, Moacir Cunha, Vita, e Campana, Methodos, Pretti, Bioclinico, a+PE, Marcelo Magalhaes, Inlab, Weinmann, a+, a+BA, IRN, CPC, and a+PI brand names. The company was founded in 1926 and is headquartered in São Paulo, Brazil.

Contact Information

Address Avenida Morumbi 8860 – 8º andar
Brooklin São Paulo, 04703-003
Brazil
Phone 55 11 5014 7236
Fax -

Top Executives

Name Age Since Title
Rui Monteiro de Barros Maciel - 2019 External Director
Samuel Monteiro dos Santos 77 - External Director
Fernando Lopes Alberto - 2000 Vice-Chairman
Octavio de Lazari 60 2017 Alternate Director
Joao Roberto Goncalves Teixeira - 2021 Independent Director
Marcio Pinheiro Mendes - 2015 Chairman
Luiz Carlos Trabuco Cappi - 2018 External Director
Mauricio Machado de Minas 64 2021 Alternate Director
Victor Cavalcanti Pardini - 2023 Independent Director
Manoel Antonio Peres 60 - Alternate Director
Regina Pardini - 2023 Independent Director
Ivan Luiz Gontijo - 2019 Director
Marcio Moura de Paula Ricardo - - Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

FLRY3 Price Commentary

Write your thoughts about Fleury SA
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email